BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10360368)

  • 1. The biological basis for the attenuation of mucositis: the example of interleukin-11.
    Sonis S; Edwards L; Lucey C
    Leukemia; 1999 Jun; 13(6):831-4. PubMed ID: 10360368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters.
    Sonis ST; Peterson RL; Edwards LJ; Lucey CA; Wang L; Mason L; Login G; Ymamkawa M; Moses G; Bouchard P; Hayes LL; Bedrosian C; Dorner AJ
    Oral Oncol; 2000 Jul; 36(4):373-81. PubMed ID: 10899677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy and chemotherapy-induced oral mucositis.
    Volpato LE; Silva TC; Oliveira TM; Sakai VT; Machado MA
    Braz J Otorhinolaryngol; 2007; 73(4):562-8. PubMed ID: 17923929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies in the treatment and prophylaxis of chemo- and radiotherapy-induced oral mucositis.
    Rosenthal C; Karthaus M; Ganser A
    Antibiot Chemother (1971); 2000; 50():115-32. PubMed ID: 10874460
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges in the local delivery of peptides and proteins for oral mucositis management.
    Campos JC; Cunha JD; Ferreira DC; Reis S; Costa PJ
    Eur J Pharm Biopharm; 2018 Jul; 128():131-146. PubMed ID: 29702221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for the management of cancer regimen-related oral mucositis.
    Villa A; Sonis ST
    Expert Opin Pharmacother; 2016 Sep; 17(13):1801-7. PubMed ID: 27477002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
    Demarosi F; Bez C; Carrassi A
    Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of oral mucositis in patients who have cancer.
    Lalla RV; Sonis ST; Peterson DE
    Dent Clin North Am; 2008 Jan; 52(1):61-77, viii. PubMed ID: 18154865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiology of mucositis.
    Sonis ST
    Semin Oncol Nurs; 2004 Feb; 20(1):11-5. PubMed ID: 15038512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy.
    Peterson DE; Cariello A
    Semin Oncol; 2004 Jun; 31(3 Suppl 8):35-44. PubMed ID: 15181607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A guide to managing the pain of treatment-related oral mucositis.
    Marlow C; Johnson J
    Int J Palliat Nurs; 2005 Jul; 11(7):338, 340-5. PubMed ID: 16116390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters.
    Sonis ST; Van Vugt AG; McDonald J; Dotoli E; Schwertschlag U; Szklut P; Keith J
    Cytokine; 1997 Aug; 9(8):605-12. PubMed ID: 9245489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based oral care for oral mucositis.
    Farrington M; Cullen L; Dawson C
    ORL Head Neck Nurs; 2013; 31(3):6-15. PubMed ID: 24069711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current approaches in prevention and therapy of chemo- and radiotherapy-induced oral mucositis].
    Rosenthal C; Karthaus M
    Wien Med Wochenschr; 2001; 151(3-4):53-65. PubMed ID: 11789420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.
    Hong BY; Sobue T; Choquette L; Dupuy AK; Thompson A; Burleson JA; Salner AL; Schauer PK; Joshi P; Fox E; Shin DG; Weinstock GM; Strausbaugh LD; Dongari-Bagtzoglou A; Peterson DE; Diaz PI
    Microbiome; 2019 Apr; 7(1):66. PubMed ID: 31018870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scoring oral mucositis.
    Parulekar W; Mackenzie R; Bjarnason G; Jordan RC
    Oral Oncol; 1998 Jan; 34(1):63-71. PubMed ID: 9659522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy.
    Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
    Support Care Cancer; 1998 Jul; 6(4):373-7. PubMed ID: 9695205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity.
    Sonis ST
    Oral Oncol; 1998 Jan; 34(1):39-43. PubMed ID: 9659518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.